| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.19 | 0.2 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |